VIVITONIN 100 TABLETS FOR AGED DOGS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

PROPENTOFYLLINE

Available from:

INTERVET AUSTRALIA PTY LIMITED

INN (International Name):

propentofylline(100mg/Tb)

Pharmaceutical form:

ORAL TABLET

Composition:

PROPENTOFYLLINE ALKALOID Active 100.0 mg/Tb

Units in package:

#100 Tabs; #Bottle; 60 Tablets; Foil strip

Class:

VM - Veterinary Medicine

Manufactured by:

INTERVET AUSTRALIA

Therapeutic group:

DOG - OLDER

Therapeutic area:

CARDIOVASCULAR SYSTEM

Therapeutic indications:

ALLEVIATION OF DULLNESS, LETHARGY | LONGEVITY | FOR OLDER DOGS | OLD AGE | PROLONG LIFE

Product summary:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG - OLDER: [ALLEVIATION OF DULLNESS, LETHARGY, LONGEVITY]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG - OLDER: [ALLEVIATION OF DULLNESS, LETHARGY, LONGEVITY]; For the alleviation of dullness, lethargy and improvement in overall demeanour in older dogs.Contraindicated in pregnant or lactating bitches, as the compound has not yet been evaluated for these animals.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

1 2 3 4 5 6
ZF
036715
CBW 880
116x48x38
286C,485C
L1482
x=15; y=70
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
VIVITONIN
®
100
VIVITONIN
®
100
TABLETS FOR AGED DOGS
60 TABLETS
TABLETS FOR AGED DOGS
ACTIVE CONSTITUENT: Each tablet contains 100 mg Propentofylline
For the alleviation of dullness, lethargy and improvement in overall
demeanour in older dogs.
60 TABLETS
Batch No.:
Expiry Date:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
VIVITONIN
®
100
TABLETS FOR AGED DOGS
60 TABLETS
DIRECTIONS FOR USE:
CONTRAINDICATIONS:
CONTRAINDICATED IN PREGNANT OR LACTATING BITCHES, AS THE COMPOUND HAS
NOT YET BEEN EVALUATED FOR THESE
ANIMALS.
DOSAGE AND ADMINISTRATION:
6 – 10 mg propentofylline/kg bodyweight daily divided into two doses
given am & pm as follows:
Bodyweight
Tablets
Daily Total
Daily Total
Kg
a.m
p.m
Tablets (100 mg)
Dose (mg/kg)
5–8
kg
fi
fi
\
6.3 – 10.0
9–15
kg
\
\
1
6.7 – 11.1
16–25
kg
¯
¯
1\
6.0 – 9.4
26–33
kg
1
1
2
6.1 – 7.7
34–50
kg
1\
1\
3
6.0 – 8.8
51–65
kg
2
2
4
6.7 – 7.8
The tablet can be administered directly onto the back of the tongue or
can be mixed with a small ball
of food. Administer the tablet on an empty stomach at least 30 minutes
before feeding. Continue
treatment as required.
FIRST AID:
If poisoning occurs, contact a doctor or Poisons Information Centre.
Phone Australia 13 11 26.
DISPOSAL: Dispose of empty container by wrapping with paper and
putting in garbage.
STORAGE: Store below 30°C (Room temperature).
APVMA Approval No.: 49892/60T/0905
INTERVET AUSTRALIA PTY LIMITED
91-105 Harpin Street, BENDIGO EAST VIC 3550
Phone: [phone]
TS FOR AGED DOGS
ctive constituent:
ntains 100mg propentofylline
ITONIN
™ 100
TS FOR AGED DOGS
ctive constituent:
ntains 100mg propentofylline
ITONIN
™ 100
TS FOR AGED DOGS
ctive constituent:
ntains 100mg propentofylline
MAL TREATMENT ONLY
ITONIN
™ 100
TS FOR AGED DOGS
ctive constituent:
ntains 100mg propentofylline
ITONIN
™ 100
TS FOR AGED D

Summary of Product characteristics

PRODUCT NAME: VIVITONIN® 50 & 100 TABLETS FOR AGED DOGS
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Propentofylline is a xanthine derivative.
TRADE NAME:
VIVITONIN
® 50 & 100 TABLETS FOR AGED DOGS
PRODUCT CODE:
176445, 176560
RECOMMENDED USE:
For the alleviation of dullness, lethargy and improvement in overall
demeanor in older
dogs. Vivitonin widens blood vessels and makes blood less sticky,
improving circulation.
APVMA NO:
51394, 49892
CREATION DATE:
November, 2006
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
Ochre coloured tablets.
ODOUR:
No odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
INHALATION:
SHORT TERM EXPOSURE:
Long term inhalation of high amounts of any nuisance dust may overload
lung clearance
mechanism. Available data indicates that this product is not harmful.
However product may be mildly irritating, although
unlikely to cause anything more than mild transient discomfort.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. In addition product is unlikely to cause any discomfort in
normal use.
LONG TERM EXPOSURE:
No data for health effects associated with long term ski